↓ Skip to main content

Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis

Overview of attention for article published in Frontiers in oncology, March 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
Published in
Frontiers in oncology, March 2020
DOI 10.3389/fonc.2020.00384
Pubmed ID
Authors

Shanawaz M. Ghouse, Hong-My Nguyen, Praveen K. Bommareddy, Kirsten Guz-Montgomery, Dipongkor Saha

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Bachelor 7 13%
Student > Ph. D. Student 6 11%
Other 4 7%
Student > Master 4 7%
Other 8 15%
Unknown 18 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 18%
Medicine and Dentistry 8 15%
Immunology and Microbiology 6 11%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 3 5%
Unknown 21 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#5,130,058
of 24,657,405 outputs
Outputs from Frontiers in oncology
#1,736
of 21,227 outputs
Outputs of similar age
#103,357
of 371,381 outputs
Outputs of similar age from Frontiers in oncology
#51
of 472 outputs
Altmetric has tracked 24,657,405 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,227 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 472 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.